401791-55-7 Usage
Structure
Benzimidazole derivative with a carboxylic acid group and a methoxy group
Explanation
The compound is derived from benzimidazole, which is a heterocyclic compound containing a benzene ring fused to an imidazole ring. It has a carboxylic acid group (-COOH) and a methoxy group (-OCH3) attached to it.
Explanation
A heterocyclic compound is a cyclic compound containing atoms of different elements, in this case, carbon, nitrogen, and oxygen. The benzene ring is fused to an imidazole ring, forming the core structure of the compound.
Explanation
Benzimidazoles and their derivatives have been found to exhibit various biological activities, which may include fighting cancer, reducing inflammation, and combating viral infections. However, the specific properties and potential applications of this particular compound would depend on further research and testing.
Explanation
The IUPAC name (International Union of Pure and Applied Chemistry) is a standardized way of naming chemical compounds. In this case, the name indicates that the compound is a benzimidazole derivative with a carboxylic acid group at the 5-position and a methoxy group at the 2-position.
Explanation
The CAS Registry Number is a unique identifier assigned to every chemical substance. The 9CI prefix indicates that 1H-Benzimidazole-5-carboxylicacid,2-methoxy-(9CI) is a derivative of benzimidazole with specific functional groups.
Explanation
While benzimidazoles and their derivatives have shown diverse biological activities, the specific properties and potential applications of 1H-Benzimidazole-5-carboxylic acid, 2-methoxy-(9CI) would need to be investigated through additional research and testing to fully understand its potential uses and effectiveness.
Heterocyclic compound
Contains a benzene ring fused to an imidazole ring
Biological activities
Potential anti-cancer, anti-inflammatory, and anti-viral properties
CAS Registry Number
9CI (Chemical Abstracts Service)
Further research and testing
Required to determine specific properties and potential applications
Check Digit Verification of cas no
The CAS Registry Mumber 401791-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,7,9 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 401791-55:
(8*4)+(7*0)+(6*1)+(5*7)+(4*9)+(3*1)+(2*5)+(1*5)=127
127 % 10 = 7
So 401791-55-7 is a valid CAS Registry Number.
401791-55-7Relevant academic research and scientific papers
NOVEL CC-1065 ANALOGS AND THEIR CONJUGATES
-
Page/Page column 147, (2010/06/17)
This invention relates to novel analogs of the DNA-alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.
Neutrophil inhibitors to reduce inflammatory response
-
Page/Page column 7, (2010/02/05)
The invention provides novel compounds selected from the group consisting of: The compounds of the present invention are useful for the treatment and prevention of a variety of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment or prevention for the above disorders using theses compounds or the compositions containing them.
